US2017065336A1PendingUtilityA1

Methods for therapeutic renal neuromodulation

Assignee: MEDTRONIC ARDIAN LUXEMBOURGPriority: Apr 8, 2002Filed: Mar 17, 2016Published: Mar 9, 2017
Est. expiryApr 8, 2022(expired)· nominal 20-yr term from priority
A61N 7/02A61N 1/36117A61N 1/327A61B 18/1492A61B 2018/00404A61B 2018/00434A61B 2018/00577A61N 7/00A61N 1/05A61N 1/36121A61N 2007/003A61F 7/12A61B 2018/00351A61N 1/36017A61N 2007/025A61N 2007/0021A61M 2210/12A61F 2007/126A61M 5/14276A61B 2018/00511A61B 2018/00267A61B 2018/0022A61M 2210/1082A61N 1/36114A61B 2018/00613
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims

exact text as granted — not AI-modified
I/We claim: 
     
         1 . A method for treating hypertension, the method comprising:
 modulating a function of a neural fiber that contributes to renal function of a kidney of a patient,   wherein modulating the function of the neural fiber further comprises modulating the function without completely physically severing the neural fiber.   
     
     
         2 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises modulating the function of the neural fiber via an electric field. 
     
     
         3 . The method of  claim 2 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a pulsed electric field. 
     
     
         4 . The method of  claim 2 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a stimulation electric field. 
     
     
         5 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises delivering a neuromodulatory agent to the neural fiber. 
     
     
         6 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises at least partially denervating the kidney. 
     
     
         7 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof. 
     
     
         8 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises thermally modulating the function of the neural fiber. 
     
     
         9 . The method of  claim 1 , wherein modulating the function of the neural fiber further comprises modulating the function of the neural fiber with high frequency ultrasound. 
     
     
         10 . A method for treating hypertension, the method comprising:
 modulating a function of a neural fiber that contributes to renal function of a kidney of a patient,   wherein modulating the function of the neural fiber further comprises modulating the function via a percutaneous approach.   
     
     
         11 . The method of  claim 10 , wherein modulating the function via a percutaneous approach further comprises modulating the function via a laparoscopic approach. 
     
     
         12 . The method of  claim 10 , wherein modulating the function via a percutaneous approach further comprises modulating the function via an endoluminal approach. 
     
     
         13 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises modulating the function of the neural fiber via an electric field. 
     
     
         14 . The method of  claim 13 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a pulsed electric field. 
     
     
         15 . The method of  claim 13 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a stimulation electric field. 
     
     
         16 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises delivering a neuromodulatory agent to the neural fiber. 
     
     
         17 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises at least partially denervating the kidney. 
     
     
         18 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof. 
     
     
         19 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises thermally modulating the function of the neural fiber. 
     
     
         20 . The method of  claim 10 , wherein modulating the function of the neural fiber further comprises modulating the function of the neural fiber with high frequency ultrasound.

Join the waitlist — get patent alerts

Track US2017065336A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.